Skip to content
haemnet
Back to The Journal of Haemophilia Practice

The Journal of Haemophilia Practice

Information for authors

The Journal of Haemophilia Practice accepts papers from all members of the multidisciplinary bleeding disorders care team, as well as outcomes research written by and/or with people affected by bleeding disorders.

We positively welcome the submission of any manuscript that is relevant to current haemophilia practice, including:

  • Original research
  • Case reports
  • Case series
  • Methodology papers
  • Reviews in any field of bleeding disorders relevant to current practice
  • Clinical updates describing current advances in any clinical field relating to bleeding disorders
  • Opinion pieces and editorials that address a particular topic of current interest.

The journal does not charge submission fees, but articles accepted for publication are subject to article processing charges (APCs) from 1 January 2024. APC waivers are available in some circumstances. See under ‘Fees and funding’ in our editorial polices and publication ethics.

Further information


Peer reviewers

The Journal of Haemophilia Practice depends on a valued network of reviewers who volunteer their time to help assess the quality of the manuscripts we receive. Through peer review, we seek experts’ fair, honest and unbiased opinion of a manuscript’s strengths and weaknesses.

We invite experts with subject-specific knowledge in all aspects of bleeding disorders care to peer review for the journal and, where relevant, others whose specialisms touch on research topics presented by the manuscripts we receive. We aim to include experts from relevant disciplines from all over the world.

If you’re interested in supporting the journal as a peer reviewer, get in touch.


Editorial policies and publication ethics

The Journal of Haemophilia Practice is committed to ensuring that our editorial processes adhere to best practice in transparency and principles of publishing, including guidelines issued by the International Committee of Medical Journal Editors (ICJME) and the Committee on Publication Ethics (COPE).

The journal may update its policies periodically as best practice recommendations evolve.

Further information


Journal management

The Journal of Haemophilia Practice (eISSN 2055-3390) is owned and managed by Haemnet Limited and published by Sciendo, part of the De Gruyters group.

Publication is continuous, throughout the year. As of January 2024, articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license (CC- BY-NC-ND 4.0).

The Editor-in-Chief is Dr Kate Khair. The Editor is Kathryn Jenner.

Email: publishing@haemnet.com


Editorial board

Alongside experts in bleeding disorders care from around the world, our editorial board  includes members of the international bleeding disorders community who work in academia and patient advocacy.

  • Sulochana B, Manipal College of Nursing, Manipal Academy of Higher Education, India
  • Tami Barazani-Brutman, Sheba Medical Center at Sheba, Tel Hashomer Hospital, Israel
  • Paul Batty, University College London, UK
  • Petra Bučková, University Hospital Brno, Czechia
  • Erica Crilly, British Columbia Children’s Hospital, Vancouver, Canada
  • Saliou Diop, Cheikh Anta Diop University, Dakar, Senegal
  • Marcela Ganzella-Sisdelli, Fundação-Hemocentro de Ribeirão, Brazil
  • Rich Gorman, Brighton and Sussex Medical School, UK
  • Cathy Harrison, Royal Hallamshire Hospital, Sheffield, UK
  • Adam Jones, University of Sunderland, UK
  • Radek Kaczmarek, Indiana University School of Medicine, USA
  • Paula Loughnane, OLCHC, Trinity College Dublin, Ireland
  • Paul McLaughlin, Royal Free Hospital, London, UK
  • Wolfgang Miesbach, Frankfurt University Hospital, Germany
  • Greta Mulders, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Jamie O’Hara, University of Chester, UK
  • Mohsena Olath, Haemophilia Association of Mauritius
  • Debra Pollard, Royal Free Hospital, London, UK
  • BJ Ramsay, Wellington Haemophilia Centre, Wellington, New Zealand
  • Robyn Shoemark, Children’s Hospital at Westmead, Sydney, Australia
  • Karen Strike, Hamilton Health Sciences, McMaster Children’s Hospital, Ontario, Canada
  • Linda Myrin Westesson, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Sally-Anne Wherry, University of Gloucestershire, Cheltenham, UK


Funding

Haemnet Ltd seeks to cover the publishing costs of The Journal of Haemophilia Practice through article processing charges (APCs). For further information, see our editorial policies and publication ethics.